Perindopril - instructions for use, reviews, analogs and formulations (2 mg, 4 mg and 8 mg tablets, including indapamide, amlodipine) for hypertension and pressure reduction in adults, children and pregnancy. Composition
In this article, you can read the instructions for using the drug Perindopril. There are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors of specialists on the use of Perindopril in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Perindopril in the presence of existing structural analogues.Use to treat hypertension and reduce blood pressure in adults, children, as well as during pregnancy and lactation. Composition of the preparation.
Perindopril - ACE inhibitor. It is a prodrug, from which an active metabolite of perindoprilat is formed in the body. It is believed that the mechanism of antihypertensive action is associated with competitive inhibition of ACE activity, which leads to a decrease in the rate of conversion of angiotensin 1 into angiotensin 2, which is a potent vasoconstrictor. As a result of a decrease in the concentration of angiotensin 2, a secondary increase in plasma renin activity occurs due to elimination of negative feedback during the release of renin and a direct decrease in aldosterone secretion. Due to vasodilator effect, reduces OPSS (afterload), wedging pressure in the pulmonary capillaries (preload) and resistance in the pulmonary vessels; increases the minute volume of the heart and tolerance to the load.
The hypotensive effect develops within the first hour after taking perindopril, reaches a maximum at 4-8 hours and lasts for 24 hours.
Composition
Perindopril erbumine + excipients.
Perindopril arginine + excipients.
Pharmacokinetics
After ingestion, perindopril is rapidly absorbed from the digestive tract. Bioavailability is 65-70%. In the process of metabolism, perindopril is biotransformed to form an active metabolite - perindoprilat (about 20%) and 5 inactive compounds. The binding of perindoprilat to plasma proteins is insignificant (less than 30%) and depends on the concentration of the active substance. Do not cumulate. Repeated reception does not result in cumulation (accumulation). When you eat while eating, the metabolism of perindopril slows down. Perindoprilat is excreted from the body by the kidneys. In elderly patients, as well as in renal and heart failure, excretion of perindoprilat slows down.
Indications
- arterial hypertension (pressure reduction);
- chronic heart failure (CHF).
Forms of release
Tablets 2 mg, 4 mg and 8 mg (including those coated).
Instructions for use and dosage
The initial dose is 1-2 mg per day in 1 dose. Supportive doses - 2-4 mg per day with congestive heart failure, 4 mg (less often - 8 mg) - with arterial hypertension in 1 dose.
In case of violations of the kidney function, a correction of the dosing regimen is required depending on the CK values.
Side effect
- dry cough;
- dyspeptic phenomena;
- dry mouth;
- violation of taste;
- headache;
- sleep and / or mood disorders;
- dizziness;
- convulsions;
- lowering of hemoglobin level (especially at the beginning of treatment);
- decrease in the number of red blood cells and / or platelets;
- reversible increase in the level of creatinine and uric acid;
- angioedema;
- skin rash;
- itching;
- erythema;
- sexual disorders.
Contraindications
- angioedema in history;
- pregnancy;
- lactation;
- childhood;
- hypersensitivity to perindopril.
Application in pregnancy and lactation
Perindopril is contraindicated in pregnancy and lactation (breastfeeding).
Use in children
Contraindicated in childhood.
special instructions
Use with caution in renal failure and severe arterial hypertension.
Before starting treatment with perindopril, all patients are recommended to study the function of the kidneys.
During treatment with perindopril, kidney function, hepatic enzyme activity in the blood, peripheral blood tests (especially in patients with diffuse connective tissue diseases, in patients receiving immunosuppressive agents, allopurinol) should be monitored regularly.Patients with sodium and liquid deficiency before the start of treatment should be corrected water-electrolyte disorders.
During treatment with perindopril, hemodialysis using polyacrylonitrile membranes can not be performed (the risk of anaphylactic reactions is increased).
Perindopril should be used with caution at the same time with drugs that can cause an increase in the level of potassium in the blood (indomethacin, cyclosporine). It is not recommended simultaneous use with potassium-sparing diuretics and potassium preparations.
Drug Interactions
When used simultaneously with antihypertensive agents, muscle relaxants, anesthesia agents, an increase in antihypertensive action is possible.
When used simultaneously with loop diuretics, thiazide diuretics, antihypertensive action may be enhanced. Severe arterial hypotension, especially after taking the first dose of a diuretic, appears to be due to hypovolemia, which leads to a transient increase in the hypotensive effect of perindopril. Increased risk of impaired renal function.
With simultaneous use with sympathomimetics, a decrease in the antihypertensive effect of perindopril is possible.
With simultaneous use with tricyclic antidepressants, antipsychotic drugs (neuroleptics) increases the risk of postural hypotension.
In an application with Indomethacin decreased antihypertensive activity of perindopril is apparently influenced by inhibiting nonsteroidal antiinflammatory drugs (NSAIDs), prostaglandin synthesis (which is believed to play a role in the development of hypotensive effect of ACE inhibitors).
When used simultaneously with insulin, hypoglycemic agents, derivatives of sulfonylureas may develop hypoglycemia due to increased tolerance to glucose.
The joint administration of perindopril and ethanol (alcohol) is not recommended, but does not have consequences for the human body.
While the use of potassium-sparing diuretics (including spironolactone, triamterene, amiloride), potassium preparations, salt substitutes and food supplements containing potassium may develop hyperkalemia (particularly in patients with impaired renal function), asACE inhibitors reduce the content of aldosterone, which leads to a delay in potassium in the body against the background of the limitation of the excretion of potassium or its additional intake into the body.
With the simultaneous application of lithium carbonate, it is possible to reduce the excretion of lithium from the body.
Analogues of Perindopril
Structural analogues of the active substance (including in combination with other elements):
- Arentopress;
- Hypernica;
- Dalnev;
- Cooverex;
- Ko Perineva;
- Noliprel;
- Noliprel A;
- Noliprel forte;
- Parnavell;
- Perindid;
- Perindopril Pfizer;
- Perindopril Richter;
- Perindopril arginine;
- Perindopril erbumine;
- Perindopril Indapamide Richter;
- Perindopril plus Indapamide;
- Perineva;
- Perinpress;
- Piristar;
- Prestan;
- Prestarium;
- Prestarium A;
- Stoppress.
Similar medicines:
Other medicines:
- Aktiferrin - instructions for use, analogs, reviews and release forms (capsules or tablets Compositum, drops, syrup), a drug for the treatment of iron deficiency in adults and children (including infants and newborns) and pregnancy
- Oftagel - instructions for use, analogs, reviews and release forms (eye gel 0.25%, drops) for the treatment of conjunctivitis, dryness and eye irritation in adults, children and pregnancy. Composition
- Herceptin - instructions for use, analogs, reviews and release forms (injections in ampoules and vials for injections and infusions, lyophilizate 150 mg and 440 mg) drugs for the treatment of breast and stomach cancer in adults, children and pregnancy. Composition